The fact that nobody knows what will happen in the economy provides surprising clarity for decision making
Category: Comment
“Great time” to invest in Southeast Asia says Eurazeo’s Shyy
CVC veteran Albert Shyy tells GCV Southeast Asian companies have emerged stronger after pandemic-related restrictions, and the expectations of investors and entrepreneurs have also become more aligned.
Retreat of Softbank and Tiger heralds a new venture era
One in which the slow, steady capital of corporate investors becomes more important.
Rising Stars Q&A – Kevin Chen, Lam Capital
Q&A with Kevin Chen, partner, Lam Capital
Raytheon’s RTX venture arm plans to build defence ecosystem
Investment in defence startups is at record levels this year, with Raytheon the latest to set up an investment arm. This is their strategy.
VC and geopolitics — when deeptech becomes the new oil for China
If venture is a “pillar of national importance,” then China has developed its soft power skills well, especially in deeptech.
Rising Stars Q&A – Daisuke Mitani, KDDI Open Innovation Fund
Q&A with Daisuke Mitani, senior director, KDDI Open Innovation Fund
CVCs need to play the “Sequoia game” in a downturn
The smartest VCs talk up a downturn but continue to invest. Corporate investors can do the same to seize opportunities when others freeze.
GCV Symposium panel: Tips for corporate investment in deeptech
Think about commercialisation early, be careful of intellectual property pitfalls and respect non-disclosure agreements.
State company investing boosts Indonesian startups
Indonesia’s VC deal numbers are in line to reach a new high this year, boosted by homegrown state-owned enterprises and interest from Asian corporates.
Ethical artificial intelligence ecosystem
The demand for ethical artificial intelligence (AI) services (including terms such as “explainable AI” or “responsible AI”) has skyrocketed, in part due to some of the troubling practices employed by large technology companies.
Understanding the benefits and threats of sensors
This special quarterly report for both the Global Healthcare Council and Global AI Council picks up how developments in one field are increasingly relevant for others.
How CVC strategies are evolving
Corporates use to struggle to get into syndicates with VCs. Now it is the VCs looking to get into a syndicate with CVCs.
This is how Chinese VC differs from US and European VC
Financial performance of a sample of Chinese VCs ranged from 14% to 30% per annum, more stable than the range of returns of European and US VC.